Literature DB >> 22683790

Structural basis for the autoinhibition of the C-terminal kinase domain of human RSK1.

Dan Li1, Tian Min Fu, Jie Nan, Cong Liu, Lan Fen Li, Xiao Dong Su.   

Abstract

p90 ribosomal S6 kinases (RSKs) respond to various mitogen stimuli and comprise two distinct protein kinase domains. The C-terminal kinase domain (CTKD) receives signal from ERK1/2 and adopts an autoinhibitory mechanism. Here, the crystal structure of human RSK1 CTKD is reported at 2.7 Å resolution. The structure shows a standard kinase fold, with the catalytic residues in the ATP-binding cleft orientated in optimal conformations for phosphotransfer. The inactivation of the CTKD is conferred by an extra α-helix (αL), which occupies the substrate-binding groove. In combination with previous knowledge, this structure indicates that activation of RSK1 involves the removal of αL from the substrate-binding groove induced by ERK1/2 phosphorylation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22683790     DOI: 10.1107/S0907444912007457

Source DB:  PubMed          Journal:  Acta Crystallogr D Biol Crystallogr        ISSN: 0907-4449


  5 in total

Review 1.  The unusual mechanism of inhibition of the p90 ribosomal S6 kinase (RSK) by flavonol rhamnosides.

Authors:  Darkhan Utepbergenov; Zygmunt S Derewenda
Journal:  Biochim Biophys Acta       Date:  2013-03-27

2.  Genome-wide pathway analysis of breast cancer.

Authors:  Young Ho Lee; Jae-Hoon Kim; Gwan Gyu Song
Journal:  Tumour Biol       Date:  2014-05-08

3.  Structural Basis of Ribosomal S6 Kinase 1 (RSK1) Inhibition by S100B Protein: MODULATION OF THE EXTRACELLULAR SIGNAL-REGULATED KINASE (ERK) SIGNALING CASCADE IN A CALCIUM-DEPENDENT WAY.

Authors:  Gergő Gógl; Anita Alexa; Bence Kiss; Gergely Katona; Mihály Kovács; Andrea Bodor; Attila Reményi; László Nyitray
Journal:  J Biol Chem       Date:  2015-11-02       Impact factor: 5.157

4.  Pathway-Affecting Single Nucleotide Polymorphisms (SNPs) in RPS6KA1 and MBIP Genes are Associated with Breast Cancer Risk.

Authors:  Ghadah Shareefi; Alaa Nabil Turkistani; Ahmed Alsayyah; Haitham Kussaibi; Maha Abdel Hadi; Khaled R Alkharsah
Journal:  Asian Pac J Cancer Prev       Date:  2020-07-01

5.  RSK1 vs. RSK2 Inhibitory Activity of the Marine β-Carboline Alkaloid Manzamine A: A Biochemical, Cervical Cancer Protein Expression, and Computational Study.

Authors:  Alejandro M S Mayer; Mary L Hall; Joseph Lach; Jonathan Clifford; Kevin Chandrasena; Caitlin Canton; Maria Kontoyianni; Yeun-Mun Choo; Dev Karan; Mark T Hamann
Journal:  Mar Drugs       Date:  2021-09-07       Impact factor: 5.118

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.